Dendreon Corp fka DNDNQ

[henrylucas]

I was one of those who asked Monique a while back about the enrollment question. I was given the same answer that Ocyan was given. I asked her 3 or 4 different ways and always came back people had started Provenge or Placebo. I found out last Wednesday that it was incorrect. When Biotechboss mentioned that Monique did not know the endpoints of P11 I emailed again and then tracked her down by phone. I was in shock when she told me the truth. Monique said it did not matter since it was event based. She had to check with others to find the truth.

This is actually good news to me. This level of bad management just tells me there is no way the BOD will allow Mitch to bring this drug to market(yes, I fired off a letter to BOD asking them what the hell was going thru their mind letting this Mngt team do what they do). The BOD will either replace the CEO or sell the company once approved.

I asked on the ymb 2 years ago that Mitch didn't decide to manage one dept badly(IR), it was just bad mngt at the very top(BOD included). This also explains why Dendreon's pps is so low. This mngt could care less about any investor retail or institutional. This also explains the treatment/answer Rancherho was given at this year's ASM.